UBS's average risk-weighted assets (as measured for regulatory capital purposes) are, today, at a similar level to 1998, just
after the UBS-SBC merger, but the underlying risk profile is very different. Today, we are a more integrated firm, our business
model has evolved, and the way we view, manage and control our risks has changed.
The primary focus in our risk-taking activities is to ensure adequate diversification of risk, and to restrict illiquid and
concentrated positions, while ensuring that we are rewarded for the risks we take. We have transferred resources from businesses
in illiquid markets into more liquid ones and have actively pursued risk distribution strategies. Portfolios with poor returns
on risk have been cut back and the quality of other portfolios has been enhanced – we have, for example, wound down the Investment
Bank's non-core loan portfolio, repositioned our private equity business and introduced risk-adjusted pricing in our Swiss
lending business.
These have been key factors in containing the level of our risk – in terms of both risk-weighted assets and risk as we measure
it internally – despite our business expansion. Our leveraged finance business, for example, has seen rapid growth in the
number and size of transactions we are involved in, but we have been successful in achieving our distribution targets and
are actively managing the residual portfolio of risk from this business. We have also securitized loans and derivatives, and
now manage much of our credit exposure in the Investment Bank using the credit derivatives market where product innovation
continues to provide new hedging opportunities.
Trading assets contribute substantially to our balance sheet but they are very liquid and the major part of the inventory
consists of highly rated securities – we have eliminated pockets of low quality, low liquidity exposure, and continuously
monitor the portfolio to identify stale and problem positions.
It is largely as a result of these efforts that we have, in the last couple of years, been in a position to speed up our entry
into new markets and assume the related risk. But while we are willing to expand into new and potentially higher risk areas
such as emerging markets, we will continue to exercise caution where this might involve illiquid and concentrated exposures.